Senseonics Holdings (SENS) Capital Expenditures Growth (1y) (2016 - 2026)
Senseonics Holdings (SENS) Capital Expenditures Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | -47.73% |
| 10 | Senseonics Holdings | 227.74 Mn | 163.42 Mn | 6.94 Mn | 50.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00% |
| Dec 31, 2025 | -244.12% |
| Sep 30, 2025 | 124.14% |
| Jun 30, 2025 | -100.84% |
| Mar 31, 2025 | 236.36% |
| Dec 31, 2024 | 585.71% |
| Sep 30, 2024 | -265.04% |
| Mar 31, 2024 | -61.40% |
| Dec 31, 2023 | -112.28% |
| Sep 30, 2023 | 179.55% |
| Mar 31, 2023 | -58.39% |
| Dec 31, 2022 | 226.67% |
| Sep 30, 2022 | 57.14% |
| Jun 30, 2022 | 105.56% |
| Mar 31, 2022 | 1,145.45% |
| Sep 30, 2021 | -82.61% |
| Jun 30, 2021 | 145.00% |
| Mar 31, 2021 | -89.00% |
| Sep 30, 2020 | -25.12% |
| Jun 30, 2020 | -123.26% |